Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Joseph Akoi Boré

AfOx Fellow 2024

Dr Joseph Akoi Boré is the Chief Executive Officer at the Centre de Recherche et d'Analyse Biomédicale (CRAM) in Guinea. He is currently a visiting fellow working with Professor Miles Carroll at the Nuffield Department of Medicine (NDM), University of Oxford, under the Africa Oxford Initiative (AfOx) Visiting Fellowship programme.

Dr Boré’s research focuses on pathogen surveillance, zoonotic spillover, and diagnostics, with an emphasis on the Ebola, Marburg, and Lassa viruses. During his career, he has led several field studies in the forested region of Guinea, contributing significantly to epidemic preparedness. Dr Boré holds a PhD in Microbiology from the University of Kent, Canterbury, and has been involved in global health initiatives, including the West African Ebola outbreak management with the European Mobile Laboratory (EMLab). His work, published in journals like The nature.com and The Lancet Infectious Diseases, showcases his expertise in viral immunology and cross-species transmission dynamics.

At Oxford, Dr Boré is advancing his project titled “Land cover change and transmission of Ebolavirus and other zoonotic pathogens in Macenta, Guinea: Integrating Spatial and Serological Data to Detect Pathogen Spillover Risk.” This project aims to develop strategies for enhancing disease surveillance in rural communities, focusing on human-wildlife interactions and land management. His work seeks to improve the Guinean healthcare system's capacity to respond to zoonotic threats, potentially strengthening regional and global epidemic preparedness.